Quick Answer
Fulgent Genetics, Inc. reported Total Revenue of $322.67 million for fiscal year 2025.
Fulgent Genetics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $322.67M | +13.8% |
| 2024 | $283.47M | -2.0% |
| 2023 | $289.21M | -53.3% |
| 2022 | $618.97M | -37.6% |
| 2021 | $992.58M | +135.4% |
| 2020 | $421.71M | +1196.5% |
| 2019 | $32.53M | +52.3% |
| 2018 | $21.35M | +14.0% |
| 2017 | $18.73M | +2.5% |
| 2016 | $18.28M | +90.9% |
| 2015 | $9.58M | +649.3% |
| 2014 | $1.28M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $84.07M | +17.2% | +2.8% |
| June 30, 2025 | $81.80M | +15.2% | +11.4% |
| March 31, 2025 | $73.46M | +13.9% | +2.4% |
| September 30, 2024 | $71.74M | -15.3% | +1.0% |
| June 30, 2024 | $71.03M | +4.7% | +10.1% |
| March 31, 2024 | $64.48M | -2.5% | -23.9% |
| September 30, 2023 | $84.69M | -19.8% | +24.8% |
| June 30, 2023 | $67.85M | -45.9% | +2.5% |
- Fulgent Genetics, Inc. showed an increase of +13.8% in Total Revenue compared to the prior fiscal year.
- Over the 2014–2025 period, Fulgent Genetics, Inc.’s total revenue has grown by 25148.1% (from $1.28 million to $322.67 million).
- The most recent figure is from Fulgent Genetics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: